FindTrial
Sign In

A cohort study on the treatment of coronary heart disease with the method of promoting qi and blood circulation (prospective)

A cohort study on the treatment of coronary heart disease with the method of promoting qi and blood circulation (prospective)

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ITMCTR
Registry ID
ITMCTR2023000064
Enrollment
Unknown
Registered
2023-12-04
Start date
2024-01-01
Completion date
Unknown
Last updated
2023-12-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Coronary heart disease

Interventions

Exposure group:Blood Activating Formula
Non-exposed group:Non-Blood-activating Formula

Sponsors

Xiyuan Hospital, China Academy of Chinese Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 85 Years

Inclusion criteria

Inclusion criteria: (1) Meeting the diagnostic criteria for coronary heart disease in Western medicine; (2) aged 18-85 years; and (3) signing an informed consent form.

Exclusion criteria

Exclusion criteria: (1) Patients with severe primary diseases such as combined hepatic and renal insufficiency, hematopoietic system abnormalities, and neurological diseases; (2) Pregnant or lactating women.

Design outcomes

Primary

MeasureTime frame
Coronary Heart Disease Chinese Medicine Symptoms Score Scale;—

Secondary

MeasureTime frame
Angina Point Scale;Seattle Angina Questionnaire;—

Countries

China

Contacts

Public ContactFang Lu

Xiyuan Hospital, China Academy of Chinese Medicine Sciences

deerfang@126.com13651132246

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026